Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Inspira Technologies Oxy BHN ( (IINN) ) has provided an announcement.
On January 14, 2025, Inspira Technologies announced the development of a modular configuration for their VORTX blood oxygenation delivery technology. This innovation is expected to expand the capabilities of the INSPIRA ART system in the critical care market, allowing for more natural blood flow and potentially reducing harm to blood components. With 32 novel patent claims, this advancement represents a significant leap in extracorporeal oxygenation technology and may enhance the versatility of the technology across various medical scenarios, potentially impacting critical care practices worldwide.
More about Inspira Technologies Oxy BHN
Inspira Technologies OXY B.H.N. Ltd. is an innovative medical technology company specializing in life support and respiratory treatment. They have developed a breakthrough device, the INSPIRA ART, which aims to transform the $19 billion mechanical ventilation market by providing an alternative to traditional mechanical ventilators. This system is designed to stabilize oxygen levels in patients while they are awake, with a real-time blood monitoring sensor called HYLA, and is targeted at the 20 million ICU patients who suffer from acute respiratory failure annually.
YTD Price Performance: 0.95%
Average Trading Volume: 639,230
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.72M
See more data about IINN stock on TipRanks’ Stock Analysis page.
